UVify to Showcase AG1-Equipped OMEGA Drone at MINExpo 2024
13.9.2024 09:00:00 CEST | ACCESS Newswire | Press release
UVify Introduces Advanced Autonomous Solutions with Rajant to Transform Mining Operations at MINExpo 2024
SEATTLE, WA / ACCESSWIRE / September 13, 2024 / UVify is excited to announce its participation at MINExpo 2024, taking place from September 24 to 26 at the Las Vegas Convention Center. UVify will be featured at partner Rajant Corporation's booth (#10741), alongside Boston Dynamics, to demonstrate the power and versatility of its Rajant-Cardinal equipped OMEGA platform (Open Modular Environment for General Autonomy).
UVify OMEGA automous drone with Rajant AG1 Cardinal Breadcrumb
UVify OMEGA at a mining site
UVify's OMEGA is designed to deliver cutting-edge autonomous solutions that enhance operational efficiency and reduce costs for the mining industry. Equipped with Rajant's Kinetic Mesh® wireless technology and Cardinal modules, the OMEGA platform enables real-time, mission-critical data transfer and seamless communication across complex mining environments. This capability provides mining operations with a robust, scalable solution for maximizing automation potential and driving both productivity and safety.
"UVify's OMEGA is poised to revolutionize the mining sector," said Robert Cheek, COO of UVify. "By integrating Rajant's advanced communication technology, we are able to provide mining companies with an intelligent, adaptable system that enhances automation capabilities and optimizes costs."
MINExpo attendees will have the opportunity to witness live demonstrations of OMEGA's autonomous features, showcasing its potential in streamlining workflows, reducing overheads, and improving overall site management. From autonomous equipment handling to fleet coordination, OMEGA offers mining operators new levels of precision and control.
About UVify
UVify is a world leader in high-performance autonomous systems and drone technologies. UVify develops cutting-edge platforms that are known for their reliability, speed, and modularity, serving industries ranging from entertainment and aerospace to mining and defense.
About Rajant Corporation
Rajant Corporation is the exclusive provider of Kinetic Mesh® wireless networks. With its industry-leading mesh networking technology, Rajant enables real-time connectivity for people, assets, and applications operating in dynamic environments.
For more information, visit www.uvify.com or join us at booth #10741 during MINExpo 2024 to see how OMEGA and Rajant-Cardinal can revolutionize your mining operations.
Press Contact
Geoff Archer
Media Relations
UVify
media@uvify.com
628-222-4032
https://www.uvify.com
Contact Information
Robert Cheek
Chief Operating Officer
robert.cheek@uvify.com
Hyon Lim
CEO
lim@uvify.com
Related Files
SOURCE: UVify
View the original press release on newswire.com.
UVify Inc.
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Karbon‑X (OTCQB:KARX) Reports Record Fiscal 2026 Revenue of $55.9 Million as Company Scales Global Carbon Market Operations1.10.2026 14:30:00 CEST | Press release
CALGARY, AB / ACCESS Newswire / October 1, 2026 / Karbon‑X Corp. (OTCQB:KARX) ("Karbon‑X" or the "Company"), a vertically integrated climate solutions company operating across global carbon markets, today reported financial and operational results for the fiscal year ended May 31, 2026, reflecting a significant increase in operating scale across its carbon credit trading and project development activities. Karbon‑X generated record fiscal 2026 revenue of $55.9 million, compared with $3.16 million in fiscal 2025, representing an increase of approximately 1,670% year over year. Gross profit was $0.86 million, compared with $0.80 million in the prior year. Fiscal 2026 results reflected a shift in revenue mix toward high-volume, lower-margin trading activity as Karbon‑X completed its first full year of large-scale carbon credit trading. "Fiscal 2026 moved Karbon-X into a new stage of commercial growth," said Chad Clovis, Chief Executive Officer of Karbon-X. "Revenue reached nearly eighteen
Surmodics Acquires Alta Biomed Business, Expanding Hemocompatible Surface Technology and Analytical Testing Capabilities1.10.2026 14:00:00 CEST | Press release
HORSHAM, PA / ACCESS Newswire / October 1, 2026 / Surmodics Inc., a leading provider of surface technologies and performance coatings for the medical device industry, today announced that it has acquired the business of Alta Biomed, a Carlsbad, California-based medical device coating and testing services company specializing in surface technologies for vascular and other medical devices. The acquisition is a strategic addition to Surmodics' growing portfolio of hemocompatible and biocompatible surface technologies. It brings Alta Biomed's proprietary PzF™ thin-film surface modification technology to Surmodics, adding an established anti-thrombotic, anti-inflammatory and pro-healing option that joins Surmodics' existing hemocompatible portfolio. "As medical device innovation advances in neuromodulation, brain-computer interfaces, neurovascular, structural heart, and venous and arterial technologies, engineers and scientists need a broader range of surface technology options to address i
PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis30.9.2026 19:00:00 CEST | Press release
PRINCETON, NJ / ACCESS Newswire / September 30, 2026 / PharmaNest, Inc. an AI-enabled digital pathology company specializing in the quantitative and spatial characterization of fibrosis and Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, today announced a collaboration to integrate advanced digital pathology into Mediar's ongoing EncompaSSc Phase 2 clinical trial of MTX-474 in patients with diffuse cutaneous systemic sclerosis (dcSSc). MTX-474 is a first-in-class human IgG1 monoclonal antibody designed to neutralize EphrinB2 signaling, a pathway implicated in myofibroblast activation, extracellular matrix (ECM) deposition and tissue remodeling known to drive fibrosis in SSc. The randomized, double-blind, placebo-controlled EncompaSSc Phase 2 study is evaluating the safety and efficacy of MTX-474 in patients with dcSSc. Under the collaboration, PharmaNest will apply its FibroNest™ AI-enabled digital path
Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans30.9.2026 15:50:00 CEST | Press release
NEW YORK, NY / ACCESS Newswire / September 30, 2026 / Innodata Inc. (Nasdaq:INOD) today announced the opening of a new R&D laboratory that is designed to generate the data needed to train the next generation of human-like robots and independently validate the performance data that robots generate internally. Innodata developed the lab in collaboration with Vicon, a leader in motion capture who consulted on the lab design and continues to provide technical consulting. The New Jersey-based lab is equipped with high-precision, low-latency infrared optical tracking cameras that measure movement down to the sub-millimeter level-a degree of accuracy that methods such as wearable inertial measurement unit (IMU) sensors and single-camera (monocular) video analysis typically cannot match. The lab addresses an urgent need for high-quality training data for humanoids, industrial robots, and other forms of physical AI. While many other data providers infer 3D motion by analyzing 2D video, Innodata
Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 202630.9.2026 00:45:00 CEST | Press release
THUNDER BAY, ON / ACCESS Newswire / September 29, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR)(FRA:CKU)(OTC PINK:CLRMF) announces that it has filed its unaudited consolidated interim financial statements and management's discussion and analysis for the six-month period ended July 31, 2026, available for viewing on www.sedarplus.ca. Financial HighlightsTotal assets as at July 31, 2026 of $35,465,204Total cash as at July 31, 2026 of $422,500Working capital deficiency as at July 31, 2026 of $3,188,114Shareholder's equity as at July 31, 2026 of $31,803,864 During the six-month period ended July 31, 2026, the Company incurred $164,309 in cost for exploration activities at the Thunder Bay North project. During the second fiscal quarter, the Company focused on finalizing the proposed amalgamation while continuing discussions on Advanced Exploration permitting and re-assessment of past geophysical work to highlight areas of focus for drilling and geophysics in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom